课题基金 / 基金详情

Transgenic & Gene-Targeting Shared Resource

Transgenic & Gene-Targeting Shared Resource
转基因
批准号:
9750035
负责人:
JAY L VIVIAN
金额:
$9.45万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

JAY L VIVIAN的其他基金

相似基金

相关文献

中文摘要
翻译
转基因和基因打靶共享资源--项目总结 转基因小鼠模型是堪萨斯大学癌症研究人员的重要工具 中心(KUCC)。这些模型的产生和分析最终会导致更好地理解 肿瘤形成的本质、进展和功能基因组学。它们也可以作为活体模型 诊断和治疗。转基因和基因打靶共享资源(TGTSR),导致Jay L.Viian 博士,通过为KUCC成员提供集中和全面的技术服务来支持KUCC成员 生产新的转基因和基因靶向啮齿动物和基因改变的多能干细胞。这个 TGTSR使用尖端方法、最先进的仪器和新的试剂来产生 这些模型。TGTSR位于KUMC园区,有四名全职技术人员和薇薇安。 癌症中心对TGTSR的支持允许在该设施中制定具体的倡议 与癌症研究相关。例如,某些转基因方法和突变特别相关 癌症研究,包括组织特异性转基因表达,临床总结的微妙突变 已确定的变异和体细胞突变以及品系特异性核移植。新兴技术,包括 体内基因组编辑方法(如CRISPR/Cas9和TALL核酸酶)提供了一种更快速的手段 产生这些类型的肿瘤进展的新型小鼠模型。这些持续不断的整合 将方法进化为TGTSR的工具箱大大加快了动物模型的发展 同时也降低了KUCC所有校区的研究人员的成本。
英文摘要
Transgenic and Gene-Targeting Shared Resource – Project Summary Genetically altered mouse models are important tools for the researchers at the University of Kansas Cancer Center (KUCC). The production and analysis of such models ultimately leads to a better understanding of the nature, progression and functional genomics of tumor formation. They also serve as in vivo models for diagnostics and treatment. The Transgenic and Gene-Targeting shared resource (TGTSR), led Jay L. Vivian PhD, supports members of KUCC by providing centralized and comprehensive technical services for the production of novel transgenic and gene-targeted rodents and genetically altered pluripotent stem cells. The TGTSR uses cutting edge methods, state-of-the-art instrumentation, and novel reagents for the generation of these models. The TGTSR, housed at the KUMC campus, has four full time technical staff along with Vivian. The Cancer Center support of the TGTSR allows for the development of specific initiatives in the Facility relevant to cancer research. For example, certain transgenic methods and mutations are particularly relevant to cancer studies, including tissue specific transgene expression, subtle mutations that recapitulate clinically identified variants and somatic mutations and strain-specific nuclear transfer. Emerging technologies, including in vivo genome editing methods (e.g. CRISPR/Cas9 and TALE nucleases) are providing a more rapid means of generating these types of novel mouse models of tumor progression. The integration of these continually evolving methods into the `toolbox' of the TGTSR greatly accelerates the development of animal models of cancer, while also reducing costs to KUCC researchers on all campuses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B: Transgenic and Gene-Targeting Institutional Facility
Transgenic & Gene-Targeting Shared Resource
Transgenic & Gene-Targeting Shared Resource
Transgenic & Gene-Targeting Shared Resource
海外基金